Analysts Lift Targets on CRL; Bears Hit Albemarle
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Analyst target prices shifted across several names on Monday. Charles River Laboratories saw its consensus target rise from $270.86 to $281.00. The contract research firm carries 7% short interest. Bears may be squeezed as 12 analysts hold buy ratings.
Albemarle moved the other way. The lithium producer's average target fell from $175.46 to $174.06. Short sellers hold 10.2% of the free float. That bearish pressure aligns with the downward analyst revision.
Arista Networks saw a recommendation removed entirely. One analyst dropped coverage on the $238 billion networking giant. The remaining 28 analysts still hold buy ratings. Short interest is minimal at 1.7% of free float.
Block stands out for sheer analyst conviction. 37 buy ratings against zero sells. The payments firm's consensus target nudged up to $96.78. That near-unanimous bullish view is rare.
Parker-Hannifin received a target lift to $1,142 from $1,134. The industrial group has 19 buy ratings. Dover Corporation saw its target trimmed slightly to $246.72. Both moves reflect cautious optimism in industrials following recent earnings seasons.
Stocks in this article
How this article was generated
- Generated
- 10 Aug 2026, 08:20
- Prompt version
- v1.0
- Data sources
- Analyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.